With a razor-sharp focus on Israeli companies and U.S. companies with Israeli interests, we provide completely integrated, cost-effective business law services, leveraging our experience and connections in the U.S., Europe, the Middle East and Asia to help advance our clients' objectives. Sullivan has had long-standing relationships in Israel for 20 years. Through our affiliation with Har-Even & Co., we have a deep bench for working on a variety of matters and issues affecting Israeli companies both in the U.S. and abroad. 

Our track record with technology, life sciences, clinical trials and global enterprises in other sectors demonstrates the value of our multi-lingual, multi-cultural team in Israel and the U.S. We understand the dynamics of very different markets, deftly bridging cultural, time-zone and language differences worldwide. Additionally, we advise on regulatory, securities and other complex corporate law and funding issues.

Clients

Our clients are industry leaders seeking to grow their businesses strategically. They are public and private companies of varied industries and idiosyncrasies that require agile, pragmatic legal advice on how to get their business what it needs.

Accolades

• IFLR1000 2022
  • Capital Markets: Debt
  • Capital Markets: Equity
• The Legal 500 EMEA 2018
  • Capital Markets
  • Commercial, Corporate & M&A
  • Hi-Tech
• Dun’s 100 2019
• BDICode 2018

Delivering on Your Next: Case Studies

Making connections and providing counsel from start-up through exit

Challenge

Mazor Robotic has been a client from its start-up days in the early 2000s through its U.S. IPO and the company's Nasdaq listing in 2013. We had helped Mazor penetrate the U.S. market, and it was poised for acquisition by Medtronic.

Getting to Next

We worked on the sale from the very beginning of the transaction and later helped with negotiations, funding and listing on the Tel Aviv stock exchange as well as Nasdaq.

Results

The client's acquisition by Medtronic for $1.6 billion was the biggest exit ever for an Israeli biomed company. This deal shows the strength of Mazor's product and the hard work of its founders, executive management and many employees.